Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

NCT04375813 ·Status: RECRUITING ·Phase: PHASE2

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

NCT02009332 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer

NCT02699853 ·Status: TERMINATED ·Phase: NA

Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer

NCT05241340 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

NCT00003725 ·Status: UNKNOWN ·Phase: PHASE3

An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

NCT04586244 ·Status: TERMINATED ·Phase: PHASE2

Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy

NCT02655081 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

NCT04579133 ·Status: TERMINATED ·Phase: PHASE2

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

NCT00080795 ·Status: COMPLETED ·Phase: PHASE2

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

NCT07043790 ·Status: COMPLETED ·Phase: NA

Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract

NCT04617756 ·Status: RECRUITING ·Phase: PHASE2

A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)

NCT03224182 ·Status: TERMINATED ·Phase: PHASE3

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

NCT06170177 ·Status: RECRUITING

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

NCT05951179 ·Status: RECRUITING ·Phase: PHASE2

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Pre-operative Immuno-Nutrition in Radical Cystectomy

NCT06355518 ·Status: NOT_YET_RECRUITING ·Phase: NA

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

NCT02145390 ·Status: TERMINATED ·Phase: NA

Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection

NCT00362713 ·Status: COMPLETED ·Phase: PHASE1

Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer

NCT05445648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

NCT02316548 ·Status: TERMINATED ·Phase: PHASE2

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

NCT00981656 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

NCT03518320 ·Status: TERMINATED ·Phase: PHASE1

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

NCT05710848 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

NCT00191711 ·Status: COMPLETED ·Phase: PHASE2